Artificial Intelligence in Drug Discovery:
Focus on Oncology (Q2 2021)
The main aim of this report is to profile an ecosystem of biotech companies and technology developers, applying advanced data analytics and knowledge extraction technologies, such as deep learning, for drug discovery in Oncology -- one of the most broad and crowded therapeutic areas of the pharmaceutical R&D and biotech investment.
This overview highlights leading AI-driven companies, their investors, selected collaborations with pharma corporations, relative expertise of such companies, level of their funding, examples of deals and collaborations, as well as examples of AI-applications by selected companies. This is an overview analysis to help the reader understand what is happening in the industry nowadays and possibly give an idea of what is coming next.